nemaura medical stock

Sign-up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter. Stock Advisor Flagship service. New Tailwind for Tesla (NASDAQ:TSLA): Have You Bought In Yet? By … Get daily stock ideas top-performing Wall Street analysts. Identify stocks that meet your criteria using seven unique stock screeners. Get the latest Nemaura Medical, Inc. NMRD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. To see all exchange delays and terms of use please see disclaimer. All rights reserved. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Sign Up. Vote “Underperform” if you believe NMRD will underperform the S&P 500 over the long term. MarketBeat's community ratings are surveys of what our community members think about Nemaura Medical and other stocks. Do Not Sell My Information. Get short term trading ideas from the MarketBeat Idea Engine. Nemaura Medical has received 52.69% “outperform” votes from our community. S&P 500 0.00%. Nemaura Medical, Inc. Common Stock (NMRD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Through its subsidiaries, it manufactures and … Nemaura Medical Inc … NEMAURA MEDICAL AKTIE und aktueller Aktienkurs. To see all exchange delays and terms of use please see disclaimer. Identify stocks that meet your criteria using seven unique stock screeners. One share of NMRD stock can currently be purchased for approximately $3.77. © American Consumer News, LLC dba MarketBeat® 2010-2021. View real-time stock prices and stock quotes for a full financial overview. View Nemaura Medical, Inc. NMRD investment & stock information. ), Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. In the past three months, Nemaura Medical insiders have not sold or bought any company stock. Nemaura Medical does not have a long track record of dividend growth. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. View the latest Nemaura Medical Inc. (NMRD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Receive a free world-class investing education from MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. ), Nemaura Medical has received 44 “underperform” votes. Apr-21-20 07:21AM : Nemaura Secures $5 Million … View which stocks have been most impacted by COVID-19. Just $1.00 for 30 days. You may vote once every thirty days. Real-time trade and investing ideas on Nemaura Medical Inc NMRD from the largest community of traders and investors. View Nemaura Medical's earnings history. Based on aggregate information from My MarketBeat watchlists, some companies that other Nemaura Medical investors own include AbbVie (ABBV), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Biocept (BIOC), Flexion Therapeutics (FLXN), Gilead Sciences (GILD), Ocular Therapeutix (OCUL), T2 Biosystems (TTOO), Agile Therapeutics (AGRX) and Amarin (AMRN). In the past three months, Nemaura Medical insiders have not sold or bought any company stock. NASDAQ 0.00%. Nemaura Medical Inc (NMRD) stock is up 23.95% over the last 12 months. Stock analysis for Nemaura Medical Inc (NMRD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View which stocks are hot on social media with MarketBeat's trending stocks report. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Based on our forecasts, a long-term increase is expected, the "NMRD" stock price prognosis for 2025-12-12 is 23.944 USD. It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; the Why WAIT app; and common law trademarks which incorporate the mark WHY WAIT or WHYWAIT and the use of licensed marks. The P/E ratio of Nemaura Medical is -18.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. With a 5-year investment, the revenue is expected to be around +468.73%. Please log in to your account or sign up in order to add this asset to your watchlist. NMRD, Nemaura Medical Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Nemaura Medical does not currently pay a dividend. Latest Company News . May-11-20 06:04AM : Nemaura reports positive data from early head-to-head comparison with a major incumbent CGM Device . Since then, NMRD stock has decreased by 40.0% and is now trading at $3.77. Nemaura Medical's mailing address is 57 WEST 57TH STREET, MANHATTAN NY, 10019. Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. One share of NMRD stock can currently be purchased for approximately $4.20. Nemaura Medical, Inc. (US:NMRD) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. The stock had a trading volume of 108,312 shares, compared to its average volume of 48,151. InvestorsObserver’s proprietary ranking system, gives NMRD stock a score of 10 out of a possible 100. You can’t afford to miss out on the once in a decade chance to buy after the recent dip in the markets. Get daily stock ideas top-performing Wall Street analysts. Looking for new stock ideas? Learn more. Nemaura Medical, Inc. Common Stock (NMRD) Nasdaq 3/18/2019 Nemaura Medical Launches BEAT(TM)diabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. See what's happening in the market right now with MarketBeat's real-time news feed. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients.

Yakima Overhaul Hd Truck Rack Accessories, Wemo Light Switch Canada, Mountain Mist Trail, 2019 Hyundai Veloster For Sale Near Me, Knock-off Bobo Bars, Funny Mosquito Commercial,